 Top 5 Insider Purchases: Which Top Managers Are Voting with Their Money for Their Companies Data from OpenInsider for May 6, 2026. While retail investors are guessing about market direction, directors and CEOs of large companies are buying up shares. Here are the most interesting deals: 1. **GE HealthCare Technologies ($GEHC)** — $5 million Director H. Lawrence Culp Jr. acquired 80,805 shares at $61.88. This is a +20% increase in his stake. The largest purchase of the day. The med-tech giant received a vote of confidence from its own board of directors. 2. **Sportradar Group ($SRAD)** — $2.13 million CEO Carsten Koerl bought 157,801 shares at $13.49. A purchase by the company's top executive is one of the strongest signals in the market. Sportradar is a monopoly in sports betting data. 3. **Angel Studios ($ANGX)** — $982K Director Steven Sarowitz increased his stake by more than 999% (from zero to 326,840 shares at $3.06). An aggressive entry amid a decline. 4. **Organon & Co. ($OGN)** — $353K SVP Lynette Holzbaur doubled her position at $13.35. Pharmaceuticals (women's health) with a dividend yield of ~5% — an insider buying on the dip. 5. **Alexandria Real Estate Equities ($ARE)** — $347K COO Joel Marcus bought 7,500 shares at $46.34. A rare purchase by top management in biotech real estate. **What this means:** When insiders invest their own money, it's a signal worth analyzing, not ignoring. Especially when it comes to CEOs and directors, not minority shareholders. → Breakdown of each deal with charts and context — in my notes. Write in the comments which company you'd like me to analyze in more detail.